"Leukemia, T-Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
| Descriptor ID |
D015458
|
| MeSH Number(s) |
C04.557.337.428.580 C15.604.515.560.575 C20.683.515.528.582
|
| Concept/Terms |
Leukemia, T-Cell- Leukemia, T-Cell
- Leukemia, T Cell
- Leukemia, Lymphocytic, T-Cell
- Lymphocytic Leukemia, T-Cell
- Leukemia, T-Cell Lymphocytic
- Leukemias, T-Cell Lymphocytic
- Lymphocytic Leukemia, T Cell
- Lymphocytic Leukemias, T-Cell
- T-Cell Lymphocytic Leukemia
- T-Cell Lymphocytic Leukemias
- T-Cell Leukemia
- Leukemias, T-Cell
- T Cell Leukemia
- T-Cell Leukemias
- T-Lymphocytic Leukemia
- Leukemia, T-Lymphocytic
- Leukemias, T-Lymphocytic
- T-Lymphocytic Leukemias
- Leukemia, Lymphocytic, T Cell
- T Lymphocytic Leukemia
- Leukemia, T Lymphocytic
- Leukemias, T Lymphocytic
- Lymphocytic Leukemia, T
- Lymphocytic Leukemias, T
- T Lymphocytic Leukemias
|
Below are MeSH descriptors whose meaning is more general than "Leukemia, T-Cell".
Below are MeSH descriptors whose meaning is more specific than "Leukemia, T-Cell".
This graph shows the total number of publications written about "Leukemia, T-Cell" by people in this website by year, and whether "Leukemia, T-Cell" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Leukemia, T-Cell" by people in Profiles.
-
Magro CM, Porcu P, Schaefer J, Erter JW, Furman RR, Shitabata PK, Crowson AN. Cutaneous CD4+ CD56+ hematologic malignancies. J Am Acad Dermatol. 2010 Aug; 63(2):292-308.
-
Ravandi F, Aribi A, O'Brien S, Faderl S, Jones D, Ferrajoli A, Huang X, York S, Pierce S, Wierda W, Kontoyiannis D, Verstovsek S, Pro B, Fayad L, Keating M, Kantarjian H. Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms. J Clin Oncol. 2009 Nov 10; 27(32):5425-30.